Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,023,169
  • Shares Outstanding, K 41,643
  • Annual Sales, $ 92,010 K
  • Annual Income, $ -23,000 K
  • 60-Month Beta 0.95
  • Price/Sales 11.12
  • Price/Cash Flow N/A
  • Price/Book 12.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.78 +17.91%
on 05/14/19
26.80 -8.58%
on 05/01/19
+1.14 (+4.88%)
since 04/24/19
3-Month
18.55 +32.08%
on 03/06/19
26.80 -8.58%
on 05/01/19
+4.82 (+24.49%)
since 02/22/19
52-Week
7.05 +247.52%
on 06/07/18
26.80 -8.58%
on 05/01/19
+16.77 (+216.95%)
since 05/24/18

Most Recent Stories

More News
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas's Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting

Veracyte, Inc. (Nasdaq: VCYT) announced today that new data demonstrating the Afirma(R) Xpression Atlas test's ability to detect gene alterations that may be targeted by new treatments...

VCYT : 24.50 (-0.28%)
Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced new data demonstrating that its next-generation Percepta(R) Genomic Sequencing Classifier (GSC)...

VCYT : 24.50 (-0.28%)
Relatively Good Performance Detected in Shares of Biomarin Pharmac in the Biotechnology Industry (BMRN , VCYT , ADMS , RTRX , EXAS )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

VCYT : 24.50 (-0.28%)
ADMS : 4.99 (-1.19%)
BMRN : 89.07 (+2.41%)
Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that it has named Sangeeta Bhorade, M.D., medical director of pulmonology. In this role, Dr. Bhorade...

VCYT : 24.50 (-0.28%)
Veracyte to Present at the UBS Global Healthcare Conference

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the...

VCYT : 24.50 (-0.28%)
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Veracyte, Inc. (Nasdaq: VCYT) announced today the closing of its public offering of 6,325,000 shares of common stock, including 825,000 shares sold upon full exercise of the underwriters'...

VCYT : 24.50 (-0.28%)
MS : 42.96 (+0.59%)
Uptrend Call Working As Veracyte Inc Stock Rises 71.6% (VCYT)

SmarTrend identified an Uptrend for Veracyte Inc (NASDAQ:VCYT) on January 4th, 2019 at $14.02. In approximately 4 months, Veracyte Inc has returned 71.61% as of today's recent price of $24.06.

VCYT : 24.50 (-0.28%)
Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock

Veracyte, Inc. (Nasdaq: VCYT) (the "Company") today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $23.25 per...

VCYT : 24.50 (-0.28%)
Relatively Good Performance Detected in Shares of Veracyte Inc in the Biotechnology Industry (VCYT , NBIX , LXRX , INCY , VRTX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

VCYT : 24.50 (-0.28%)
LXRX : 5.92 (+2.78%)
NBIX : 79.89 (+1.45%)
Veracyte Announces Proposed Public Offering of Common Stock

Veracyte, Inc. (Nasdaq: VCYT) ("the Company") today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. All of the shares are being offered...

VCYT : 24.50 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade VCYT with:

Business Summary

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also...

See More

Key Turning Points

2nd Resistance Point 25.29
1st Resistance Point 24.89
Last Price 24.50
1st Support Level 24.18
2nd Support Level 23.87

See More

52-Week High 26.80
Last Price 24.50
Fibonacci 61.8% 19.26
Fibonacci 50% 16.92
Fibonacci 38.2% 14.59
52-Week Low 7.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar